Fibrin D-dimer, Markers of Coagulation Activation and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study
- 1 January 2001
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 86 (09) , 822-827
- https://doi.org/10.1055/s-0037-1616138
Abstract
We have previously reported that plasma fibrin D-dimer (a marker of turnover of cross-linked fibrin) showed a strong and independent association with incident ischaemic heart disease (IHD) in the Caerphilly Study cohort of 1,998 men aged 49-65. To establish the specificity of this finding, we assayed plasma samples from this cohort with a more specific assay for fibrin D-dimer: this showed an association with incident IHD which was at least as strong and independent as that for the original assay (odds ratio, OR for top fifth compared to bottom fifth 3.79; 95% CI 1.77-8.10; p < 0.0001). To establish potential causes of the increased fibrin turnover, we also assayed several potential markers of coagulation activation or thrombotic tendency (prothrombin fragment F1+2, thrombin-antithrombin complexes, factor VIIc, activated partial thromboplastin time [APTT] and activated protein C resistance): none of these variables were associated with incident IHD in this cohort. We suggest that further studies are required to establish the causes of increased cross-linked fibrin turnover, which is associated with incident IHD in the general population when measured by a specific assay.Keywords
This publication has 12 references indexed in Scilit:
- Thrombogenic Factors and Recurrent Coronary EventsCirculation, 1999
- The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studiesBritish Journal of Haematology, 1998
- Fibrin D-dimer, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and the Risk of Major Ischaemic Heart Disease in the Caerphilly StudyThrombosis and Haemostasis, 1998
- EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USEBritish Journal of Haematology, 1997
- Fibrin D-Dimer: A Useful Clinical Marker of Thrombogenesis?Clinical Science, 1995
- Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.Heart, 1995
- Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasmaBritish Journal of Haematology, 1995
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery diseaseThrombosis Research, 1992
- Increased fibrin turnover in peripheral arterial disease: Comparison with a population studyClinical Hemorheology and Microcirculation, 1992